백색 생명공학(White Biotechnology) 기술 동향, 주요 기업 및 시장 전망 2025-2035

화학물질 및 소재분야를 위한 산업용 바이오 제조, 산업 발효 공정, 35종 이상의 바이오 기반 분자에 대한 기술 분석 및 전망, 바이오 제조 시장 분석 및 향후 10년간 시장 전망을 포괄하는 보고서

모두 보기 설명 목차, 표 및 그림 목록 자주 묻는 질문 가격 Related Content
백색 생명공학(White biotechnology) 기반 생산은 규제압력과 바이오 기반 산업공정으로의 전환에 따라 지속적으로 성장하고 있으며, 향후10년간 연평균 11.1%의 성장률(CAGR)을 기록할 것으로 예상됩니다. 이 보고서에서는 바이오 제조분야에서 나타나고 있는 주요 트랜드 및 핵심 산업분야에 걸쳐 35개 이상의 바이오 기반 제품들을 분석하고 있으며, 효소 공학(enzyme engineering), 합성 생물학(synthetic biology)과 같은 핵심 기술들을 평가하고, 주요 시장 참여자 동향, 최근 생산공장 폐쇄 사례, 상업화 과정의 도전과제 및 규제환경의 변화를 포함하여 향후 10년간 시장 예측 및 전망을 제공합니다.
이 보고서에서 아래와 같은 주요 정보를 제공합니다.
 
  • 바이오경제 내에서 백색 생명공학의 역할에 대한 논의
  • 연료, 플라스틱, 섬유, 첨가제, 전구체 및 기타 화학물질 분야에서의 바이오 제조 응용 개요
  • 바이오 제조를 통해 생산되는 40종 이상의 바이오 기반 분자 식별
  • 주요 바이오 제조 분자에 대한 30건 이상의 상세 기술 분석 : 제조 공정, 기술 성숙도(TRL), 기술적 과제, 석유 기반 기존 기술과의 비교, 다운스트림 응용분야 등
  • 프로판디올, PHA, 아디핀산 등 주요 바이오 기반 분자의 현재 생산 능력과 전망에 대한 벤치마킹
  • 합성 생물학 및 산업 바이오 제조에 미치는 영향 분석
  • 탄소 포집, 기체 및 리그노셀룰로오스계 원료, 새로운 바이오 촉매 등 백색 생명공학에 영향을 미치는 기술 개발 동향
  • AI 및 머신러닝을 통한 기술 발전이 바이오 제조에 미치는 영향
  • 정부정책, 브랜드, 대중 인식 등 시장 성장 요인과 백색 생명공학의 주요 기술적 과제 평가
  • 산업 바이오 제조의 경제적 타당성을 저해하는 문제점 분석
  • 현재 진행중인 프로젝트 및 과거의 사례를 통한 백색 생명공학의 성공/실패 요인 분석
  • 젖산, 부탄디올, PHA, 숙신산 및 기타 유기산을 포함한 주요 바이오 제조 분자별로 세분화된 10년 시장 전망
  • 100개 이상의 신생 스타트업과 기존 기업 식별 및 바이오 제조 분자별 분류
 
이 보고서에서 다루는 주요 내용/목차는 아래와 같습니다.
 
1. 핵심 요약 및 결론
2. 백색 생명공학의 신흥 기술 트랜드
  • 합성 생물학
  • 바이오촉매
  • 무세포 시스템
  • 지속가능성
  • 대체 원료
3. 백색 생명공학의 주요 제품
  • 연료(에탄올, 조류 기반 바이오연료 등)
  • 폴리머 전구체(젖산, 숙신산, 부탄디올, 아디프산 등)
  • 기타 화학물질(유기산, 트라이글리세라이드, 지방산 등)
  • 새로운 기능성 소재(거미줄, 균사체 등)
4. 백색 생명공학 시장 분석 - 성장 동인, 경제성, 기술적 과제
5. 산업 바이오제조 스타트업 및 주요 기업 현황
6. 인터뷰 기반 기업 프로필
7. 백색 생명공학 10개 부문의 시장 규모, 예측 및 전망
 
White biotechnology: Advancing the bioeconomy
The bioeconomy can be defined as an economic system in which society uses renewable biological resources (i.e. derived from land, fisheries, and aquaculture environments) to create biobased products such as food and nutrients, chemicals and materials, and bio-energy. Developing the bioeconomy is a key aspect of creating a more circular sustainable economy, an especially critical task as the effects of climate change are exacerbated by global reliance on fossil fuel resources.
 
The advancement of biotechnology is critical to expanding the bioeconomy, as different areas (or "colors") of biotechnology can positively improve different sectors of the economy. For example, "green" biotechnology may be used to improve agricultural yields, while "red" biotechnology may be applied towards the creation of new vaccines. Of the numerous colors of the biotechnology spectrum, white biotechnology stands out as a key technology enabler for the bioeconomy by advancing the industrial production of biobased products through biological systems.
 
In this report, "White Biotechnology 2025-2035", IDTechEx provides independent analysis of the status of white biotechnology, looking critically at technology innovations and historic, current, and future projects to provide an objective assessment of white biotechnology's future.
 
What is white biotechnology, and why does it matter?
White biotechnology, sometimes called industrial biomanufacturing, is the industrial production and processing of chemicals, materials, and energy using living cell factories, like bacteria, yeast, and fungi. White biotechnology represents a more sustainable alternative to petroleum-based chemical production: one that not only decreases society's reliance on fossil fuels but also uses less energy, generates less waste, and potentially creates biodegradable products that are better for the environment.
 
Current distribution of white biotechnology installed production capacity by region 2025. Source: IDTechEx
 
White biotechnology is not particularly new; engineered enzymes for detergents have been produced via white biotechnology since the 1980s, and bacterial enzymes have been used as food additives for many, many years. That begs the question: why is white biotechnology so interesting now?
 
IDTechEx, in this report, sheds light on the technology innovations driving white biotechnology's growth and increasing relevance. With improvements in biotechnology tools and processes comes the ability to produce numerous important products, from commodity chemicals to high performance textiles, through white biotechnology. One main technology driver is synthetic biology - the artificial design and engineering of biological systems and living organisms for the purpose of improving applications for industry or research. IDTechEx offers extensive discussion on synthetic biology's importance to industrial biomanufacturing by considering synthetic biology's tools and techniques, applications, emerging players, etc. IDTechEx continues their analysis of the technology advances enabling white biotechnology with detailed examinations (including status, technical benefits and challenges, commercial activity), among other trends, of:
  • Novel biocatalysts for industrial fermentation
  • Improvements to bioprocesses
  • Cell-free systems
  • Alternative feedstocks for bioreactors - gases, cellulosic materials, etc.
  • Carbon neutral and carbon negative biomanufacturing
 
Biobased products from industrial biomanufacturing: a diverse spectrum
Just as important as the innovations improving white biotechnology are its applications - the chemicals, precursors, additives, and materials produced by the fermentation of engineered cell factories. The range of molecules and compounds that can be biomanufactured is incredibly diverse with use cases in everything from lubricants to leather, textiles to packaging, adhesives to additives, etc. These molecules include alcohols, diols, diamines, organic acids, proteins, and more.
 
To provide clarity on these many products of white biotechnology, IDTechEx provides detailed technical and market analysis on 40+ biomanufactured molecules, looking at essential factors for each molecule such as:
  • The molecule's biomanufacturing process
  • Comparison of the biomanufactured product with its petrochemical equivalent
  • Technical advantages of the biomanufacturing process
  • Current challenges
  • Downstream products and end-applications for the molecule
  • Technology readiness level
  • Players developing and producing the molecule via biomanufacturing
  • Market outlook
 
With these IDTechEx insights, a clear understanding of the status and growing versatility of the white biotechnology industry will be achieved.
 
Lactic acid: Experiencing accelerating growth through regulation-driven PLA demand
Among the many biobased molecules covered in this report, lactic acid stands out for its rapidly growing significance, driven largely by increased demand for polylactic acid (PLA). PLA, a biodegradable polymer derived from lactic acid, is gaining momentum as a substitute for traditional fossil-based plastics in packaging and consumer goods. This surge in demand is notably influenced by tightening environmental regulations, particularly in China, where restrictions on non-biodegradable plastics have spurred a national push toward compostable alternatives. As a result, both domestic and international PLA producers are scaling up production capacity, fueling parallel growth in the lactic acid supply chain.
 
The Impact of AI on White Biotechnology
Artificial intelligence (AI) is increasingly becoming a pivotal enabler in the development and optimization of white biotechnology. By accelerating strain engineering, AI algorithms can analyze genomic and metabolic datasets to predict optimal genetic modifications for improved yield, tolerance, or productivity in microbial cell factories. In bioprocess development, machine learning models are being used to optimize fermentation conditions in silico, reducing the need for costly and time-consuming laboratory trials. AI also plays a vital role in enzyme discovery and protein engineering by rapidly screening candidate molecules for industrial use. As white biotechnology continues to expand its application scope, the integration of AI stands to dramatically improve process efficiency, scalability, and cost effectiveness, reinforcing the field's value proposition as a sustainable alternative to traditional petrochemical production.
 
White biotechnology: An active market of established and emerging players
With the diverse spectrum of molecules being produced through white biotechnology, there is a large number of companies attempting to advance their industrial biomanufacturing activities. Within this report, IDTechEx has considered well over 100 companies pursuing white biotechnology efforts, ranging from multinational material and chemical conglomerates to nascent startups. Important information such as partnerships, funding, past projects, molecules being pursued, current production capacity, and more are highlighted to understand how and why so many companies have chosen to engage with white biotechnology. These will be bolstered by IDTechEx's interview-based company profiles of key players in this market.
 
The player landscape of white biotechnology is just one component of the overall market dynamics that are shaping industrial biomanufacturing. There are numerous factors to be evaluated to determine the economic viability of certain white biotechnology projects, from internal factors such as process yield, ease of scale, and biocatalyst choice to external factors such as government regulations, crude oil prices, and the green premium. This report analyzes the white biotechnology market from these perspectives to offer understanding on the industry's prior trajectory and insight on what will determine its future success.
 
White biotechnology 10-year market forecast segmented by major molecules
 
Colors of biotechnology: defining the scope of white biotechnology. Source: IDTechEx
 
Lastly, to identify the growth potential of the white biotechnology industry, IDTechEx provides industrial biomanufacturing forecasts that segments the market by ten major biomanufactured molecules based on global production capacity. The report looks at the current capacity, drivers, and constraints of each segment and then extrapolates them into a 10-year forecast, to explore the mature and emerging white biotechnology products, technology readiness, potential for disruption, and the future landscape of white biotechnology.
Key Aspects:
  • Discussion of white biotechnology within the bioeconomy.
  • Overview of biomanufacturing's application in fuels, plastics, textiles, additives, precursors, and other chemicals.
  • Identification of 40+ biobased molecules produced through biomanufacturing.
  • 30+ granular technology analyses for major biomanufactured molecules, including biomanufacturing process, technology readiness level, challenges, comparison against petroleum incumbent, and downstream applications.
  • Benchmarking of current production capacity and outlook for major biobased molecules, including propanediol, PHAs, adipic acid, etc.
  • Analysis of synthetic biology and its impact on industrial biomanufacturing.
  • Technology developments influencing white biotechnology, including carbon capture, gaseous and lignocellulosic feedstock, and novel biocatalysts.
  • The impact of technology developments with AI and machine learning on biomanufacturing.
  • Assessment of market drivers (government legislation, brands, the public) and key technical challenges for white biotechnology.
  • Pain points affecting economic viability for industrial biomanufacturing.
  • Discussion of current projects and previous efforts in white biotechnology, including analysis of factors for success or failure.
  • Detailed 10-year market forecasts segmented by major biomanufactured molecules, including lactic acid, butanediol, PHAs, succinic acid, and other organic acids.
  • Identification of 100+ emerging startups and established players operating in industrial biomanufacturing, segmented by molecule.
Report MetricsDetails
CAGRBiomanufactured chemicals to grow at 11.1% CAGR from 2025-2035 (excluding fuels).
Forecast Period2025 - 2035
Forecast Unitskilotonnes per annum (ktpa)
Regions CoveredWorldwide
Segments CoveredLactic Acid, 1,3-propanediol, Long chain dicarboxylic acids (LCDAs), Succinic Acid, PHA, Other Biomanufactured Chemicals, Short chain fatty acids (SCFAS), 1,4-butanediol, 1,5-pentanediamine, Other organic acids
IDTechEx의 분석가 액세스
모든 보고서 구입에는 전문가 분석가와의 최대 30분의 전화통화 시간이 포함되어, 보고서의 주요 결과를 귀하가 제시하는 비즈니스 문제에 연결하도록 돕습니다. 이 전화통화는 보고서를 구매한 후 3개월 이내에 사용해야합니다.
추가 정보
이 보고서에 대해 궁금한 점이 있으시면 언제든지 research@IDTechEx.com으로 보고서 팀에 문의하거나, 영업 관리자에게 문의하십시오

AMERICAS (USA): +1 617 577 7890
ASIA (Japan): +81 3 3216 7209
ASIA (Korea): +82 10 3896 6219
EUROPE (UK) +44 1223 812300
1.EXECUTIVE SUMMARY
1.1.Glossary of terms
1.2.Colors of biotechnology
1.3.What is white biotechnology?
1.4.White Biotechnology 2025-2035: scope
1.5.Trends and drivers in white biotechnology
1.6.Synthetic biology as applied to white biotechnology
1.7.Technology trends in white biotechnology
1.8.Overview of alternative feedstocks for white biotechnology
1.9.Major market challenges for white biotechnology
1.10.Technical challenges facing white biotechnology
1.11.Products derived from white biotechnology: Overview
1.12.Molecules that can be produced through industrial biomanufacturing
1.13.Molecules that can be produced through industrial biomanufacturing
1.14.Company landscape in white biotechnology
1.15.Company landscape in white biotechnology
1.16.Next-generation fuels through white biotechnology
1.17.Bioplastics through white biotechnology
1.18.Navigating biobased polymers from monosaccharides
1.19.Common bioplastics and polymer precursors synthesized via white biotechnology
1.20.Status of molecules produced through white biotechnology
1.21.White biotechnology market share by molecule 2025-2035
1.22.White biotechnology global capacity forecast 2025-2035
1.23.White biotechnology global capacity forecast 2025-2035: Discussion (I)
1.24.White biotechnology global capacity forecast 2025-2035: Discussion (II)
1.25.Emerging areas of white biotechnology forecast 2025-2035
1.26.IDTechEx circular bioeconomy research
1.27.Company profiles
1.28.Access More With an IDTechEx Subscription
2.INTRODUCTION
2.1.Glossary of acronyms
2.2.Glossary of acronyms
2.3.Glossary of terms
2.4.Glossary of terms
2.5.Colors of biotechnology
2.6.What is white biotechnology?
2.7.The bioeconomy and white biotechnology
2.8.White Biotechnology 2025-2035: Scope
3.MARKET ANALYSIS
3.1.Market Drivers for White Biotechnology
3.1.1.Market drivers: Demand for biobased products
3.1.2.Market drivers: Government regulation on petroleum-based plastic use
3.1.3.Market drivers: Regulations that are likely to impact biomanufacturing demand
3.1.4.Market drivers: Regulations are driving strong interest in biodegradable plastics in China
3.1.5.Market drivers: Government support of biotechnology
3.1.6.Market drivers: Government support of biotechnology
3.1.7.Market drivers: Carbon taxes
3.2.Economic Viability of White Biotechnology
3.2.1.Factors affecting the economic viability of white biotechnology projects
3.2.2.Effect of the price of Brent crude on biobased products
3.2.3.The Green Premium
3.2.4.Rising feedstock prices
3.2.5.Effect of cell factory on cost
3.2.6.Identifying the chemicals with the most potential to become biobased based on price
3.2.7.How scale-up affects cost
3.2.8.Zymergen: Case study on economics of synthetic biology
3.2.9.Case study: LanzaTech
3.2.10.Case study: Solazyme
3.2.11.Synthetic biology: Shift from commodity products to lower volume, high value markets
3.2.12.Major market challenges for white biotechnology
3.3.Player, Start-up, and Regional Landscape
3.3.1.Production capacity of chemicals from biomanufacturing by region 2025
3.3.2.Regional analysis: Drivers and restraints for biomanufacturing production and demand by region
3.3.3.Regional analysis: Location of R&D vs production
3.3.4.Regional analysis: Biomanufacturing
3.3.5.Regional analysis: Production capacity by region
3.3.6.Players: Synthetic biology tools and platforms
3.3.7.Players: Vertically integrated biomanufacturing
3.3.8.Emerging players segmented by molecule
3.3.9.Emerging players segmented by molecule
3.3.10.Overview of chemicals and materials companies involved with white biotechnology
3.3.11.Overview of chemicals and materials companies involved in white biotechnology
4.CELL FACTORIES FOR WHITE BIOTECHNOLOGY
4.1.Cell factories for biomanufacturing: Factors to consider
4.2.Cell factories for biomanufacturing: A range of organisms
4.3.Escherichia coli (E.coli)
4.4.Corynebacterium glutamicum (C. glutamicum)
4.5.Bacillus subtilis (B. subtilis)
4.6.Saccharomyces cerevisiae (S. cerevisiae)
4.7.Yarrowia lipolytica (Y. lipolytica)
4.8.Microorganisms used in different biomanufacturing processes
4.9.Non-model organisms for white biotechnology
5.TECHNOLOGY DEVELOPMENTS
5.1.Synthetic Biology
5.1.1.Synthetic biology: The design and engineering of biological systems
5.1.2.Synthetic biology: Manipulating the central dogma
5.1.3.The vast scope of synthetic biology
5.1.4.The process of synthetic biology: Design, build and test
5.1.5.Synthetic biology: Why now?
5.1.6.Synthetic biology: From pharmaceuticals to consumer products
5.1.7.Synthetic biology: Disrupting existing supply chains
5.1.8.Synthetic biology: Drivers and barriers for adoption
5.1.9.Synthetic biology as applied to white biotechnology
5.2.Tools and Techniques of Synthetic Biology
5.2.1.Tools and techniques of synthetic biology: Overview
5.2.2.DNA synthesis
5.2.3.Introduction to CRISPR-Cas9
5.2.4.CRISPR-Cas9: A bacterial immune system
5.2.5.CRISPR-Cas9's importance to synthetic biology
5.2.6.Protein/enzyme engineering
5.2.7.Computer-aided design
5.2.8.Commercial examples of engineered proteins in industrial applications
5.2.9.Strain construction and optimization
5.2.10.Synergy between synthetic biology and metabolic engineering
5.2.11.Framework for developing industrial microbial strains
5.2.12.The problem with scale
5.2.13.Introduction to cell-free systems
5.2.14.Cell-free versus cell-based systems
5.2.15.Cell-free systems in the context of white biotechnology
5.2.16.Cell-free systems for white biotechnology
5.2.17.Commercial implementation of cell-free systems: Solugen
5.2.18.Startups pursuing cell-free systems for white biotechnology
5.2.19.Startups pursuing cell-free systems for white biotechnology
5.2.20.Immobilized enzymes in white biotechnology
5.2.21.Immobilized catalysts in white biotechnology
5.2.22.Robotics: enabling hands-free and high throughput science
5.2.23.Robotic cloud laboratories
5.2.24.Automating organism design and closing the loop
5.2.25.Artificial intelligence and machine learning
5.2.26.Machine learning de novo protein prediction
5.2.27.Overview of machine learning based improvements for biomanufacturing
5.2.28.AI-driven fermentation platform companies
5.3.Improvement of Biomanufacturing Processes
5.3.1.Continuous vs batch biomanufacturing
5.3.2.Benefits and challenges of continuous biomanufacturing
5.3.3.Continuous vs batch biomanufacturing: Key fermentation parameter comparison
5.3.4.Machine learning to improve biomanufacturing processes
5.3.5.Downstream processing (DSP) improvements
5.3.6.Downstream processing (DSP) improvements (2)
5.3.7.Perfusion bioreactors
5.3.8.Tangential flow filtration (TFF) in downstream bioprocessing
5.3.9.Hybrid biotechnological-chemical approaches
5.3.10.Process intensification and high-cell-density fermentation
5.4.White Biotechnology for Sustainability
5.4.1.White biotechnology as a sustainable technology
5.4.2.Routes for carbon capture in white biotechnology
5.4.3.Autotrophic bacteria for carbon capture through biomanufacturing
5.5.Alternative Feedstocks for Biomanufacturing
5.5.1.Why use alternative feedstocks for white biotechnology?
5.5.2.Food, land, and water competition
5.5.3.C1 feedstocks: Metabolic pathways
5.5.4.C1 feedstocks: Economic benefits
5.5.5.C1 feedstocks: Challenges
5.5.6.Non-methane C1 feedstocks
5.5.7.C1 feedstocks: Products
5.5.8.C1 feedstocks: Gas fermentation
5.5.9.C2 feedstocks
5.5.10.C2 feedstocks: Products segmented by feedstock
5.5.11.C1 and C2 feedstocks: Commercial activity
5.5.12.C1 and C2 feedstocks: Commercial activity
5.5.13.Lignocellulosic biomass feedstocks
5.5.14.Lignocellulosic biomass feedstocks: Challenges
5.5.15.Lignocellulosic biomass feedstocks: Challenges
5.5.16.Lignocellulosic biomass feedstocks: Products
5.5.17.Lignocellulosic biomass feedstocks: Products
5.5.18.Lignocellulosic feedstocks: Commercial activity
6.BLUE BIOTECHNOLOGY
6.1.What is blue biotechnology?
6.2.Main biocatalysts of blue biotechnology: Cyanobacteria and algae
6.3.Cyanobacteria
6.4.Algae
6.5.Key drivers and challenges for blue biotechnology
6.6.Selected startups in blue biotechnology
7.PRODUCTS DERIVED FROM WHITE BIOTECHNOLOGY
7.1.1.Products derived from white biotechnology: Overview
7.2.Fuels
7.2.1.Biofuel generations - conventional & advanced biofuels
7.2.2.Biofuel generations
7.2.3.Biofuels made from white biotechnology
7.2.4.Metabolic pathways to biofuels
7.2.5.Bioethanol
7.2.6.Next-generation bioethanol
7.2.7.Next generation bioethanol: Barriers
7.2.8.Next-generation ethanol - operational plants
7.2.9.Next-generation ethanol - operational plants
7.2.10.Next-generation ethanol - operational plants
7.2.11.Next-generation ethanol - operational plants
7.2.12.Next-generation ethanol - operational plants
7.2.13.Next-generation ethanol - planned plants
7.2.14.Next-generation ethanol - planned plants
7.2.15.Next-generation ethanol - non-operational and cancelled plants
7.2.16.Next-generation ethanol - non-operational and cancelled plants
7.2.17.Diesel from biomanufacturing pathways
7.2.18.Farnesene
7.2.19.n-Butanol
7.2.20.Isobutanol
7.2.21.Methanol
7.2.22.Blue biotechnology in biofuel production
7.2.23.Blue biotechnology in biodiesel production
7.2.24.Blue biotechnology in bioethanol production
7.2.25.Blue biotechnology for biofuel production: Key challenges for commercial viability
7.2.26.Blue biotechnology for biofuel production: Commercial activity by US oil producers
7.2.27.Blue biotechnology for biofuel production: Commercial activity by non-US oil producers
7.2.28.Blue biotechnology for biofuel production: List of current and former players
7.2.29.Blue biotechnology for biofuel production: List of current and former players
7.2.30.Blue biotechnology for biofuel production: List of current and former players
7.3.Plastics and Textiles
7.3.1.Introduction to bioplastics
7.3.2.Production of bioplastics through white biotechnology
7.3.3.Navigating biobased polymers from monosaccharides
7.3.4.Common bioplastics and polymer precursors synthesized via white biotechnology
7.3.5.Lactic Acid and Polylactic Acid (PLA)
7.3.6.Lactic acid (C3H6O3)
7.3.7.Lactic acid: Bacterial fermentation or chemical synthesis?
7.3.8.Optimal lactic acid bacteria strains for fermentation
7.3.9.Engineering yeast strains for lactic acid fermentation
7.3.10.Fermentation, recovery and purification
7.3.11.What is polylactic acid?
7.3.12.Production of PLA
7.3.13.PLA production process
7.3.14.Polylactic acid: A SWOT analysis
7.3.15.Molecules for Other Biobased Synthetic Polyesters
7.3.16.The range of available biobased polyesters from bio-manufactured monomers
7.3.17.Propylene glycol (PG) or 1,2-propanediol
7.3.18.1,3-Propanediol (1,3-PDO)
7.3.19.Biobased PDO and PTT: Monomer production
7.3.20.Biobased PDO and PTT: Polymer applications
7.3.21.2,3-Butanediol (2,3-BDO)
7.3.22.1,4-Butanediol (1,4-BDO)
7.3.23.Biobased BDO: Monomer production
7.3.24.Biobased BDO technology licensed from Geno
7.3.25.Biobased BDO and PBT: Polymer applications
7.3.26.Succinic acid
7.3.27.Biobased succinic acid: Monomer production
7.3.28.Biobased succinic acid and PBS: Polymer applications
7.3.29.Biobased succinic acid: Project status
7.3.30.2,5-furandicarboxylic acid (FDCA)
7.3.31.Biobased FDCA: Monomer production
7.3.32.Polyethylene furanoate (PEF)
7.3.33.Biobased FDCA and PEF: Polymer applications
7.3.34.Molecules for Other Biobased Synthetic Polymers
7.3.35.Biosynthetic pathways to polyamides
7.3.36.C6: Adipic acid, hexamethylenediamine, and caprolactam
7.3.37.C10: Sebacic acid
7.3.38.C12: Dodecanedioic acid
7.3.39.1,5-Pentanediamine (PDA)
7.3.40.Covestro: PDI and Desmodur eco aliphatic polyisocyanate
7.3.41.Cathay Industrial Biotech: TERRYL and ECOPENT biobased polyamides
7.3.42.1,3-Butadiene
7.3.43.Status of biomanufacturing-derived butadiene projects
7.3.44.Isoprene
7.3.45.Isobutene (isobutylene)
7.3.46.Naturally Occurring Biobased Polymers: Polyhydroxyalkanoates (PHAs)
7.3.47.Introduction to poly(hydroxyalkanoates)
7.3.48.Biosynthetic pathways to PHAs
7.3.49.Fermentation, recovery and purification
7.3.50.Key commercial PHAs and microstructures
7.3.51.PHB, PHBV, and P(3HB-co-4HB)
7.3.52.Types of PHAs
7.3.53.Material properties of commercial PHAs
7.3.54.Suppliers of PHAs
7.3.55.Short and medium chain-length PHAs
7.3.56.PHAs: A SWOT analysis
7.3.57.Applications of PHAs
7.3.58.Opportunities in PHAs
7.3.59.Reducing the cost of PHA production
7.3.60.Risks in PHAs
7.3.61.PHAs are only made in small quantities
7.3.62.PHA production facilities
7.3.63.Case Study: Danimer Scientific ends PHA production
7.3.64.Conclusions
7.3.65.Other Textiles Produced through White Biotechnology
7.3.66.Spider silk
7.3.67.Collagen-derived textiles
7.3.68.Mycelium
7.4.Other Chemicals, Precursors, and Additives
7.4.1.Acetone
7.4.2.Acrylic acid
7.4.3.Acetone
7.4.4.Itaconic acid
7.4.5.Biobased ethanol as a precursor
7.4.6.Biomanufacturing of ethylene
7.4.7.Monoethylene glycol (MEG)
7.4.8.Biobased MEG: Monomer production
7.4.9.Biobased MEG: Industry landscape
7.4.10.Biobased MEG: Industry landscape
7.4.11.Polyethylene terephthalate (PET)
7.4.12.Biobased polyolefins
7.4.13.Braskem: "I'm green" polyethylene
7.4.14.Biomanufacturing of propylene precursors
7.4.15.Malonic acid
7.4.16.Short chain fatty acids and medium chain fatty acids (SCFAs/MCFAs)
7.4.17.Short chain fatty acids and medium chain fatty acids (SCFAs/MCFAs)
7.4.18.Short chain fatty acids: Acetic acid
7.4.19.Triglycerides
7.4.20.Other organic acids and aldehydes
7.4.21.Other organic acids and aldehydes
7.4.22.Bacterial cellulose
7.5.Other Products Derived from White Biotechnology
7.5.1.Overview of vitamins and amino acids produced through white biotechnology
7.5.2.Overview of white biotechnology for cosmetics
7.5.3.Biomanufacturing for surfactants and detergents
7.5.4.Enzymes for onward use: Novozymes
7.5.5.Cement alternatives from biomanufacturing: BioMason
7.5.6.Precision fermentation: Definition and scope
8.FORECASTS FOR WHITE BIOTECHNOLOGY
8.1.Forecast methodology
8.2.White biotechnology market share by molecule 2025-2035
8.3.White biotechnology global capacity forecast 2025-2035
8.4.White biotechnology global capacity forecast 2025-2035: Discussion (I)
8.5.White biotechnology global capacity forecast 2025-2035: Discussion
8.6.White biotechnology global capacity forecast 2025-2035: Discussion
8.7.Emerging areas of white biotechnology forecast 2025-2035
8.8.Emerging areas of white biotechnology forecast: Discussion
9.COMPANY PROFILES
9.1.Afyren
9.2.Arzeda
9.3.Biomason
9.4.Bolt Threads
9.5.Braskem
9.6.Cathay Biotech
9.7.CarbonBridge
9.8.Celtic Renewables
9.9.Chaincraft
9.10.CyanoCapture
9.11.Ecovative
9.12.Enginzyme
9.13.Enzymaster
9.14.Industrial Microbes
9.15.Kraig Biocraft Laboratories
9.16.LanzaTech (2023) Update
9.17.LanzaTech
9.18.Mango Materials
9.19.Modern Meadow
9.20.New Energy Blue
9.21.Novozymes
9.22.Q Power
9.23.Spiber
9.24.Henan Techuang Biotechnology
9.25.Huitong Biomaterials
9.26.Total Energies Corbion
9.27.Teijin Frontier: PLA
9.28.Natureworks
9.29.Biotic Circular Technologies
9.30.Bluepha
9.31.CJ Biomaterials
9.32.Danimer Scientific (2024 Update - Now bankrupt)
9.33.Danimer Scientific
9.34.Fortum: INGA Plastic
9.35.Kaneka
9.36.Newlight Technologies (Not currently operational)
9.37.Ourobio
9.38.Paques Biomaterials
10.APPENDIX
10.1.White biotechnology global capacity forecast 2025-2035
10.2.Emerging areas of white biotechnology forecast 2025-2035
 

About IDTechEx reports

What are the qualifications of the people conducting IDTechEx research?

Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their specialist field, and all of whom are employees. All our analysts are well-connected in their fields, intensively covering their sectors, revealing hard-to-find information you can trust.

How does IDTechEx gather data for its reports?

By directly interviewing and profiling companies across the supply chain. IDTechEx analysts interview companies by engaging directly with senior management and technology development executives across the supply chain, leading to revealing insights that may otherwise be inaccessible.
 
Further, as a global team, we travel extensively to industry events and companies to conduct in-depth, face-to-face interviews. We also engage with industry associations and follow public company filings as secondary sources. We conduct patent analysis and track regulatory changes and incentives. We consistently build on our decades-long research of emerging technologies.
 
We assess emerging technologies against existing solutions, evaluate market demand and provide data-driven forecasts based on our models. This provides a clear, unbiased outlook on the future of each technology or industry that we cover.

What is your forecast methodology?

We take into account the following information and data points where relevant to create our forecasts:
  • Historic data, based on our own databases of products, companies' sales data, information from associations, company reports and validation of our prior market figures with companies in the industry.
  • Current and announced manufacturing capacities
  • Company production targets
  • Direct input from companies as we interview them as to their growth expectations, moderated by our analysts
  • Planned or active government incentives and regulations
  • Assessment of the capabilities and price of the technology based on our benchmarking over the forecast period, versus that of competitive solutions
  • Teardown data (e.g. to assess volume of materials used)
  • From a top-down view: the total addressable market
  • Forecasts can be based on an s-curve methodology where appropriate, taking into account the above factors
  • Key assumptions and discussion of what can impact the forecast are covered in the report.

How can I be confident about the quality of work in IDTechEx reports?

Based on our technical analysts and their research methodology, for over 25 years our work has regularly received superb feedback from our global clients. Our research business has grown year-on-year.
 
Recent customer feedback includes:
"It's my first go-to platform"
- Dr. Didi Xu, Head of Foresight - Future Technologies, Freudenberg Technology Innovation
 
"Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
- Ralf Hug, Global Head of Product Management & Marketing, Marquardt

What differentiates IDTechEx reports?

Our team of in-house technical analysts immerse themselves in industries over many years, building deep expertise and engaging directly with key industry players to uncover hard-to-find insights. We appraise technologies in the landscape of competitive solutions and then assess their market demand based on voice-of-the-customer feedback, all from an impartial point of view. This approach delivers exceptional value to our customers—providing high-quality independent content while saving customers time, resources, and money.

Why should we pick IDTechEx research over AI research?

A crucial value of IDTechEx research is that it provides information, assessments and forecasts based on interviews with key people in the industry, assessed by technical experts. AI is trained only on content publicly available on the web, which may not be reliable, in depth, nor contain the latest insights based on the experience of those actively involved in a technology or industry, despite the confident prose.

How can I justify the ROI of this report?

Consider the cost of the IDTechEx report versus the time and resources required to gather the same quality of insights yourself. IDTechEx analysts have built up an extensive contact network over many years; we invest in attending key events and interviewing companies around the world; and our analysts are trained in appraising technologies and markets.
 
Each report provides an independent, expert-led technical and market appraisal, giving you access to actionable information immediately, rather than you having to spend months or years on your own market research.

Can I speak to analysts about the report content?

All report purchases include up to 30 minutes of telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

What is the difference between a report and subscription?

A subscription from IDTechEx can include more reports, access to an online information platform with continuously updated information from our analysts, and access to analysts directly.

Before purchasing, I have some questions about the report, can I speak to someone?

Please email research@idtechex.com stating your location and we will quickly respond.

About IDTechEx

Who are IDTechEx's customers?

IDTechEx has served over 35,000 customers globally. These range from large corporations to ambitious start-ups, and from Governments to research centers. Our customers use our work to make informed decisions and save time and resources.

Where is IDTechEx established?

IDTechEx was established in 1999, and is headquartered in Cambridge, UK. Since then, the company has significantly expanded and operates globally, having served customers in over 80 countries. Subsidiary companies are based in the USA, Germany and Japan.

Questions about purchasing a report

How do I pay?

In most locations reports can be purchased by credit card, or else by direct bank payment.

How and when do I receive access to IDTechEx reports?

When paying successfully by credit card, reports can be accessed immediately. For new customers, when paying by bank transfer, reports will usually be released when the payment is received. Report access will be notified by email.

How do I assign additional users to the report?

Users can be assigned in the report ordering process, or at a later time by email.

Can I speak to someone about purchasing a report?

Please email research@idtechex.com stating your location and we will quickly respond.
 

Ordering Information

백색 생명공학(White Biotechnology) 기술 동향, 주요 기업 및 시장 전망 2025-2035

£$¥
전자 (사용자 1-5명)
£5,650.00
전자 (사용자 6-10명)
£8,050.00
전자 및 1 하드 카피 (사용자 1-5명)
£6,450.00
전자 및 1 하드 카피 (사용자 6-10명)
£8,850.00
전자 (사용자 1-5명)
€6,400.00
전자 (사용자 6-10명)
€9,100.00
전자 및 1 하드 카피 (사용자 1-5명)
€7,310.00
전자 및 1 하드 카피 (사용자 6-10명)
€10,010.00
전자 (사용자 1-5명)
$7,000.00
전자 (사용자 6-10명)
$10,000.00
전자 및 1 하드 카피 (사용자 1-5명)
$7,975.00
전자 및 1 하드 카피 (사용자 6-10명)
$10,975.00
전자 (사용자 1-5명)
元50,000.00
전자 (사용자 6-10명)
元72,000.00
전자 및 1 하드 카피 (사용자 1-5명)
元58,000.00
전자 및 1 하드 카피 (사용자 6-10명)
元80,000.00
전자 (사용자 1-5명)
¥990,000
전자 (사용자 6-10명)
¥1,406,000
전자 및 1 하드 카피 (사용자 1-5명)
¥1,140,000
전자 및 1 하드 카피 (사용자 6-10명)
¥1,556,000
전자 (사용자 1-5명)
₩9,800,000
전자 (사용자 6-10명)
₩14,000,000
전자 및 1 하드 카피 (사용자 1-5명)
₩11,200,000
전자 및 1 하드 카피 (사용자 6-10명)
₩15,400,000
Click here to enquire about additional licenses.
If you are a reseller/distributor please contact us before ordering.
お問合せ、見積および請求書が必要な方はm.murakoshi@idtechex.com までご連絡ください。
연료를 제외한 바이오 기반 화학물질 시장은 2025년부터 2035년까지 연평균 11.1%의 성장률(CAGR)을 기록할 것으로 전망

보고서 통계

슬라이드 315
전망 2035
게시 Apr 2025
 

콘텐츠 미리보기

pdf Document Sample pages
 

Customer Testimonial

quote graphic
"The resources provided by IDTechEx, such as their insightful reports and analysis, engaging webinars, and knowledgeable analysts, serve as valuable tools and information sources... Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
Global Head of Product Management and Marketing
Marquardt GmbH
 
 
 
ISBN: 9781835701171

Subscription Enquiry